| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AVTX | Avalo Therapeutics, Inc. | NEIL GARRY ARTHUR | CEO and Chairman of the Board | Jun 09, 2023 | Buy | $3.42 | 4,000 | 13,680 | 13,220 | Jun 13, 2023, 04:39 PM | |
| AVTX | Avalo Therapeutics, Inc. | NEIL GARRY ARTHUR | CEO and Chairman of the Board | Dec 09, 2022 | Buy | $4.42 | 2,083 | 9,207 | 9,220 | Dec 12, 2022, 04:22 PM | |
| AVTX | Avalo Therapeutics, Inc. | NEIL GARRY ARTHUR | Chief Scientific Officer | Dec 10, 2021 | Buy | $1.57 | 4,267 | 6,699 | 85,639 | Dec 14, 2021, 05:15 PM | |
| CERC | Cerecor Inc. | NEIL GARRY ARTHUR | Chief Scientific Officer | Jun 10, 2021 | Buy | $2.28 | 3,692 | 8,418 | 81,372 | Jun 14, 2021, 05:04 PM | |
| CERC | Cerecor Inc. | NEIL GARRY ARTHUR | Chief Scientific Officer | Dec 10, 2020 | Buy | $2.28 | 3,599 | 8,199 | 77,680 | Dec 14, 2020, 04:06 PM | |
| CERC | Cerecor Inc. | NEIL GARRY ARTHUR | Chief Scientific Officer | Jun 10, 2020 | Buy | $2.28 | 1,799 | 4,098 | 74,081 | Jun 11, 2020, 09:02 PM | |
| GNMX | Aevi Genomic Medicine, Inc. | NEIL GARRY ARTHUR | Chief Scientific Officer | Dec 05, 2019 | Buy | $0.13 | 2,049,376 | 274,616 | 2,164,150 | Dec 09, 2019, 09:12 PM | |
| GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Jan 02, 2019 | Option Exercise | $0.86 | 14,535 | 12,500 | 36,759 | Jan 03, 2019, 04:27 PM | |
| GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Oct 01, 2018 | Option Exercise | $1.50 | 8,333 | 12,500 | 22,224 | Oct 02, 2018, 05:02 PM | |
| GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Jul 02, 2018 | Option Exercise | $15.47 | 808 | 12,500 | 13,891 | Jul 03, 2018, 11:05 AM | |
| GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Apr 02, 2018 | Option Exercise | $17.47 | 716 | 12,509 | 13,083 | Apr 03, 2018, 04:46 PM | |
| GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Jan 02, 2018 | Option Exercise | $11.46 | 1,091 | 12,503 | 12,367 | Jan 04, 2018, 12:40 PM | |
| GNMX | Aevi Genomic Medicine, Inc. | NEIL GARRY ARTHUR | Chief Scientific Officer | Oct 17, 2017 | Buy | $1.26 | 75,000 | 94,500 | 114,774 | Oct 18, 2017, 04:16 PM | |
| GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Oct 02, 2017 | Option Exercise | $7.94 | 1,574 | 12,498 | 11,277 | Oct 04, 2017, 04:06 PM | |
| GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Jul 03, 2017 | Option Exercise | $5.26 | 2,376 | 12,498 | 9,702 | Jul 05, 2017, 12:00 AM | |
| GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Apr 03, 2017 | Option Exercise | $4.90 | 2,551 | 12,500 | 7,326 | Apr 05, 2017, 04:58 PM | |
| GTXI | GTX INC /DE/ | NEIL GARRY ARTHUR | Director | Jan 03, 2017 | Option Exercise | $5.21 | 2,399 | 12,499 | 4,775 | Jan 04, 2017, 05:03 PM | |
| MDGN | MEDGENICS, INC. | NEIL GARRY ARTHUR | Chief Scientific Officer | Oct 06, 2015 | Buy | $6.50 | 15,384 | 99,996 | 39,774 | Oct 08, 2015, 04:46 PM | |
| MDGN | MEDGENICS, INC. | NEIL GARRY ARTHUR | Global Head of R&D | Dec 01, 2014 | Buy | $4.10 | 24,390 | 99,999 | 24,390 | Dec 02, 2014, 08:51 AM |
Menu